---
figid: PMC9410866__JIR2022-8023915.005
pmcid: PMC9410866
image_filename: JIR2022-8023915.005.jpg
figure_link: /pmc/articles/PMC9410866/figure/fig5/
number: Figure 5
figure_title: ''
caption: The PI3K/AKT/mTOR signaling pathway. (a) Protein expression of PI3K, phosphorylated
  PI3K, AKT, phosphorylated AKT, mTOR, phosphorylated mTOR, and β-actin by western
  blot in CT26 cells treated with PBS, cisplatin, HA-Cis, and HA-mPEG-Cis NPs (cisplatin
  equivalent of 3 μg/mL). (b) Relative protein expression of PI3K and p-PI3K. (c)
  Relative protein expression of AKT and p-AKT. (d) Relative protein expression of
  mTOR and p-mTOR. ∗∗P < 0.01.
article_title: PEGylated Cisplatin Nanoparticles for Treating Colorectal Cancer in
  a pH-Responsive Manner.
citation: Wei Li, et al. J Immunol Res. 2022;2022:8023915.
year: '2022'

doi: 10.1155/2022/8023915
journal_title: Journal of Immunology Research
journal_nlm_ta: J Immunol Res
publisher_name: Hindawi

keywords:
---
